转化性心力衰竭在人环素和化剂化疗后
Amresh Gul1, Zahid Khan2,3,4
1General Practice, GP Clinic, Brisbane, AUS.
Cureus
|January 26, 2026
概括
化疗可以导致心力衰竭 (HF),但治疗可以改善心脏功能. 该病例显示,在使用指南导向医学治疗 (GDMT) 治疗化疗诱导心肌病后,左心室喷射小部分 (LVEF) 的恢复.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心脏毒性是癌症治疗的严重并发症,影响患者的治疗结果.
- 化疗引起的心力衰竭 (HF) 呈现出复杂的病理生理机制.
- 了解这些机制对于预防和治疗策略至关重要.
研究的目的:
- 报告化疗诱导心肌病症 (心力衰竭与减少喷射率 - HFrEF) 的病例.
- 用指南导向医学治疗 (GDMT) 来说明心脏恢复潜力.
主要方法:
- 一个41岁的女性为乳腺癌接受治疗的病例报告.
- 评估左心室喷射分数 (LVEF) 通过心声图,在以人环素为基础的化疗 (多克索鲁比和环胺) 之前和之后.
- 使用指南导向医学疗法 (GDMT) 进行管理.
主要成果:
- 患者在化疗后发展了HFrEF,LVEF下降到39%.
- 在GDMT之后,LVEF在6个月后改善到45%,在12个月后改善到50-55%.
- 证明了显著的心脏恢复和改善的LVEF.
结论:
- 化疗诱导的心肌病是癌症治疗中的一个重要问题.
- 在HFrEF患者中,指南导向医疗疗 (GDMT) 可以导致大量的心脏恢复.
- 优化药理管理是改善心脏毒性病幸存者的治疗结果的关键.
相关概念视频
Heart Failure Drugs: Inotropic Agents
1.4K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.4K
Pathophysiology of Heart Failure
3.2K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction
776
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
776
Heart Failure II: Pathophysiology
837
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
837
Heart Failure Drugs: Diuretics
893
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
893
Heart Failure V: Medical Management
256
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
256


